{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:14:57Z","timestamp":1792275297132,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10067-020-05276-0","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T12:07:27Z","timestamp":1594642047000},"page":"753-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Influence of glutathione S transferase A1 gene polymorphism (-69C\u2009&gt;\u2009T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-265X","authenticated-orcid":false,"given":"Doaa H. S.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamees A.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"5276_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","volume":"15","author":"N Danchenko","year":"2006","unstructured":"Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308\u2013318","journal-title":"Lupus"},{"key":"5276_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/B978-0-323-31696-5.00079-6","volume-title":"Kelley and Firestein\u2019s textbook of rheumatology","author":"MK Crow","year":"2017","unstructured":"Crow MK (2017) Etiology and pathogenesis of systemic lupus erythematosus. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR et al (eds) Kelley and Firestein\u2019s textbook of rheumatology, 10th edn. Elsevier, Philadelphia, pp 1329\u20131344","edition":"10"},{"key":"5276_CR3","first-page":"1368","volume-title":"Kelley and Firestein\u2019s textbook of rheumatology","author":"G Bertsias","year":"2007","unstructured":"Bertsias G, Fanouriakis A, Boumpas DT (2007) Treatment of systemic lupus erythematosus. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR et al (eds) Kelley and Firestein\u2019s textbook of rheumatology, 10th edn. Elsevier, Philadelphia, pp 1368\u20131389","edition":"10"},{"key":"5276_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7326\/0003-4819-135-4-200108210-00009","volume":"135","author":"GG Illei","year":"2001","unstructured":"Illei GG, Austin HA, Crane M et al (2001) Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 135:248\u2013257","journal-title":"Ann Intern Med"},{"key":"5276_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/art.1780340803","volume":"34","author":"AD Steinberg","year":"1991","unstructured":"Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945\u2013950","journal-title":"Arthritis Rheum"},{"key":"5276_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA 3rd, Vaughn EM et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741\u2013745","journal-title":"Lancet"},{"key":"5276_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/rheumatology\/kep346","volume":"49","author":"D Isenberg","year":"2010","unstructured":"Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, S\u00e1nchez-Guerrero J, Wofsy D, Yu X, Solomons N (2010) Influence of race\/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology (Oxford) 49:128\u2013140","journal-title":"Rheumatology (Oxford)"},{"key":"5276_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6","volume":"41","author":"CC Mok","year":"1998","unstructured":"Mok CC, Lau CS, Wong RW (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41:831\u2013837","journal-title":"Arthritis Rheum"},{"key":"5276_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/art.1780380815","volume":"38","author":"CD Radis","year":"1995","unstructured":"Radis CD, Kahl LE, Baker GL, Wasko MCM, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA, Kwoh CK (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis: a 20-year followup study. Arthritis Rheum 38:1120\u20131127","journal-title":"Arthritis Rheum"},{"key":"5276_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","volume":"44","author":"ME de Jonge","year":"2005","unstructured":"de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH (2005) Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 44:1135\u20131164","journal-title":"Clin Pharmacokinet"},{"key":"5276_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.clim.2015.07.010","volume":"160","author":"HN Wang","year":"2015","unstructured":"Wang HN, Zhu XY, Zhu Y, Xie QH, Lai LY, Zhao M, Chen YC, Xue J, Hao CM, Gu Y, Lin SY (2015) The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients. Clin Immunol 160:342\u2013348","journal-title":"Clin Immunol"},{"key":"5276_CR12","first-page":"6215","volume":"54","author":"HA Dirven","year":"1994","unstructured":"Dirven HA, van Ommen B, van Bladeren BJ (1994) Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res 54:6215\u20136220","journal-title":"Cancer Res"},{"key":"5276_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51\u201388","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5276_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000028396","volume":"61","author":"JD Hayes","year":"2000","unstructured":"Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154\u2013166","journal-title":"Pharmacology"},{"key":"5276_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/bj2350741","volume":"235","author":"C Guthenberg","year":"1986","unstructured":"Guthenberg C, Warholm M, Rane A, Mannervik B (1986) Two distinct forms of glutathione transferase from human foetal liver. Purification and comparison with isoenzymes isolated from adult liver and placenta. Biochem J 235:741\u2013745","journal-title":"Biochem J"},{"key":"5276_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1021\/tx00050a009","volume":"8","author":"AE Mitchell","year":"1995","unstructured":"Mitchell AE, Morin D, Lame MW, Jones AD (1995) Purification, mass spectrometric characterization, and covalent modification of murine glutathione S-transferases. Chem Res Toxicol 8:1054\u20131062","journal-title":"Chem Res Toxicol"},{"key":"5276_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/bj3160131","volume":"316","author":"P Jemth","year":"1996","unstructured":"Jemth P, Stenberg G, Chaga G, Mannervik B (1996) Heterologous expression, purification and characterization of rat class theta glutathione transferase T2-2. Biochem J 316:131\u2013136","journal-title":"Biochem J"},{"key":"5276_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.leukres.2011.06.020","volume":"36","author":"JL Black","year":"2012","unstructured":"Black JL, Litzow MR, Hogan WJ, O\u2019Kane DJ, Walker DL, Lesnick TG, Kremers WK, Avula R, Ketterling RP (2012) Ketterling, correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients. Leuk Res 36:59\u201366","journal-title":"Leuk Res"},{"key":"5276_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.10896","volume":"103","author":"C Sweeney","year":"2003","unstructured":"Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF, Coles BF (2003) Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer 103:810\u2013814","journal-title":"Int J Cancer"},{"key":"5276_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/cncr.20729","volume":"103","author":"G Yang","year":"2005","unstructured":"Yang G, Shu XO, Ruan ZX, Cai QY, Jin F, Gao YT, Zheng W (2005) Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 103:52\u201358","journal-title":"Cancer"},{"key":"5276_CR21","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.1073\/pnas.191211198","volume":"98","author":"JM Allan","year":"2001","unstructured":"Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ (2001) Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A 98:11592\u201311597","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5276_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.bjc.6602891","volume":"94","author":"E Goekkurt","year":"2006","unstructured":"Goekkurt E, Hoehn S, Wolschke C, Wittmer C, Stueber C, Hossfeld DK, Stoehlmacher J (2006) Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) \u2013 novel predictors for response and survival in gastric cancer patients. Br J Cancer 94:281\u2013286","journal-title":"Br J Cancer"},{"key":"5276_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ygyno.2005.08.035","volume":"100","author":"A Beeghly","year":"2006","unstructured":"Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H (2006) Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100:330\u2013337","journal-title":"Gynecol Oncol"},{"key":"5276_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/cncr.21619","volume":"106","author":"C Lu","year":"2006","unstructured":"Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, Blumenschein GR, Hong WK, Wu X (2006) Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 106:441\u2013447","journal-title":"Cancer"},{"key":"5276_CR25","first-page":"1004","volume":"53","author":"J Brockmoller","year":"1993","unstructured":"Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I (1993) Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res 53:1004\u20131011","journal-title":"Cancer Res"},{"key":"5276_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1078-0432.CCR-0844-03","volume":"10","author":"SM Yule","year":"2004","unstructured":"Yule SM, Price L, McMahon AD, Pearson AD, Boddy AV (2004) Cyclophosphamide metabolism in children with non-Hodgkin\u2019s lymphoma. Clin Cancer Res 10:455\u2013460","journal-title":"Clin Cancer Res"},{"key":"5276_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151696","volume":"11","author":"A Audemard-Verger","year":"2016","unstructured":"Audemard-Verger A, Silva NM, Verstuyft C et al (2016) Glutathione S transferases polymorphisms are independent prognostic factors in lupus nephritis treated with cyclophosphamide. PLoS One 11:e0151696","journal-title":"PLoS One"},{"key":"5276_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5414\/CN106886","volume":"75","author":"J Winoto","year":"2011","unstructured":"Winoto J, Song H, Hines C, Nagaraja H, Rovin BH (2011) Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy. Clin Nephrol 75:451\u2013457","journal-title":"Clin Nephrol"},{"key":"5276_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2125.2006.02690.x","volume":"62","author":"S Zhong","year":"2006","unstructured":"Zhong S, Huang M, Yang X, Liang L, Wang Y, Romkes M, Duan W, Chan E, Zhou SF (2006) Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 62:457\u2013472","journal-title":"Br J Clin Pharmacol"},{"key":"5276_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/03602530500364023","volume":"37","author":"J Zhang","year":"2006","unstructured":"Zhang J, Tian Q, Yung CS et al (2006) Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metab Rev 37:611\u2013703","journal-title":"Drug Metab Rev"},{"key":"5276_CR31","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725\u20131734","journal-title":"Arthritis Rheum"},{"key":"5276_CR32","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A, Alarc\u00f3n G et al (2012) Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686","journal-title":"Arthritis Rheum"},{"key":"5276_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/art.21625","volume":"54","author":"Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria","year":"2006","unstructured":"Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2006) The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 54:421\u2013432","journal-title":"Arthritis Rheum"},{"key":"5276_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241\u2013250","journal-title":"J Am Soc Nephrol"},{"key":"5276_CR35","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D et al (2002) Immunosuppressive therapy in lupus nephritis: the euro-lupus nephritis trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121\u20132131","journal-title":"Arthritis Rheum"},{"key":"5276_CR36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"key":"5276_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/toxsci\/kfj037","volume":"89","author":"J Ping","year":"2006","unstructured":"Ping J, Wang H, Huang M, Zhi-su (2006) Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci 89:438\u2013443","journal-title":"Toxicol Sci"},{"key":"5276_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00467-004-1759-7","volume":"20","author":"U Vester","year":"2005","unstructured":"Vester U, Kranz B, Zimmermann S, B\u00fcscher R, Hoyer PF (2005) The response to cyclophosphamide in steroid- sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases- M1 and -P1. Pediatr Nephrol 20:478\u2013481","journal-title":"Pediatr Nephrol"},{"key":"5276_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drup.2005.08.003","volume":"8","author":"J Zhang","year":"2005","unstructured":"Zhang J, Tian Q, Chan SY, Duan W, Zhou S (2005) Insights into oxazaphosphorine resistance and possible approaches to its circumvention. Drug Resist Updat 8:271\u2013297","journal-title":"Drug Resist Updat"},{"key":"5276_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/annonc\/mdf052","volume":"13","author":"AD Huitema","year":"2002","unstructured":"Huitema AD, Spaander M, Mathjt RA et al (2002) Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin. Ann Oncol 13:374\u2013384","journal-title":"Ann Oncol"},{"key":"5276_CR41","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME et al (2003) Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 101:2043\u20132048","journal-title":"Blood"},{"key":"5276_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0019-509X.31164","volume":"44","author":"C Girish","year":"2007","unstructured":"Girish C, Manikandan S (2007) Aprepitant: a substance P antagonist for chemotherapy induced nausea and vomiting. Indian J Cancer 44:25\u201330","journal-title":"Indian J Cancer"},{"key":"5276_CR43","first-page":"1625","volume":"66","author":"JH Fetting","year":"1982","unstructured":"Fetting JH, McCarthy LE, Borison HL, Colvin M (1982) Vomiting induced by cyclophosphamide and phosphoramide mustard in cats. Cancer Treat Rep 66:1625\u20131629","journal-title":"Cancer Treat Rep"},{"key":"5276_CR44","volume-title":"Encyclopedia of Systems Biology","author":"W Haynes","year":"2013","unstructured":"Haynes W (2013) Bonferreoni correction. In: Dubitzky W, Wolkenhauer O, Cho KH, Yokota H (eds) Encyclopedia of Systems Biology. Springer, New York"},{"key":"5276_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2307\/3315468","volume":"20","author":"RD Routledge","year":"1992","unstructured":"Routledge RD (1992) Resolving the conflict over Fisher\u2019s exact test. The Can J Stat 20:201\u2013209","journal-title":"The Can J Stat"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05276-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:22:37Z","timestamp":1650536557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05276-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5276"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05276-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"9 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Research Ethics Committee of the Rheumatology and Rehabilitation Department, Cairo University; and it conformed to the 1995 provisions of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}